Méndez SN, Díaz OL, Córdova GJ (2021) Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience. J Hepatol 75(1):221–222. https://doi.org/10.14218/JCTH.2021.00408

Article  Google Scholar 

Liebig M, Dannenberger D, Vollmar B, Abshagen K (2019) Endogenously increased n-3 PUFA levels in fat-1 transgenic mice do not protect from non-alcoholic steatohepatitis. Hepatobiliary Surg Nutr 8(5):447–458. https://doi.org/10.21037/hbsn.2019.04.03

Article  PubMed  PubMed Central  Google Scholar 

Gofton C, Upendran Y, Zheng MH, George J (2023) MAFLD: how is it different from NAFLD? Clin Mol Hepatol 29(Suppl):S17–S31. https://doi.org/10.3350/cmh.2022.0367

Article  PubMed  Google Scholar 

Barchetta I, Cimini FA, Cavallo MG (2020) Vitamin D and metabolic dysfunction-Associated fatty liver Disease (MAFLD): an update. Nutrients 12(11):3302. https://doi.org/10.3390/nu12113302

Article  CAS  PubMed  PubMed Central  Google Scholar 

Charoenngam N, Holick MF (2020) Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients 12(7):2097. https://doi.org/10.3390/nu12072097

Article  CAS  PubMed  PubMed Central  Google Scholar 

Szymczak PI, Drzewoski J, Śliwińska A (2020) The Molecular mechanisms by which Vitamin D Prevents Insulin Resistance and Associated disorders. Int J Mol Sci 21(18):6644. https://doi.org/10.3390/ijms21186644

Article  CAS  Google Scholar 

Zhang J, Li Y, Lai D, Lu D, Lan Z, Kang J, Xu Y, Cai S (2021) Vitamin D status is negatively related to Insulin Resistance and bone turnover in Chinese non-osteoporosis patients with type 2 diabetes: a retrospective Cross-section Research. Front Public Health 9:727132. https://doi.org/10.3389/fpubh.2021.727132

Article  PubMed  Google Scholar 

Cutolo M, Smith V, Paolino S, Gotelli E (2023) Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19. Nat Rev Rheumatol 19(5):265–287. https://doi.org/10.1038/s41584-023-00944-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barbalho SM, Tofano RJ, de Campos AL, Rodrigues AS, Quesada K, Bechara MD, de Alvares Goulart R, Oshiiwa M (2018) Association between vitamin D status and metabolic syndrome risk factors. Diabetes Metab Syndr 12(4):501–507. https://doi.org/10.1016/j.dsx.2018.03.011

Article  PubMed  Google Scholar 

Paul L (2021) Vitamin D to prevent acute respiratory infections. Lancet Diabetes Endocrinol 9(5):249–251. https://doi.org/10.1016/s2213-8587(21)00075-9

Article  CAS  Google Scholar 

Khosa SNH, Mustafa K, Ahmad K (2017) Vitamin D deficiency - A risk factor for breast cancer. Pakistan J Med Health Sci 11(3):992–994. https://doi.org/10.1200/JCO.2023.41.16_suppl.10559

Article  Google Scholar 

Barchetta I, Angelico F, Ben MD, Baroni MG, Pozzilli P, Morini S, Cavallo MG (2011) Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC med 9:85. https://doi.org/10.1186/1741-7015-9-85

Article  CAS  PubMed  PubMed Central  Google Scholar 

Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, Arcaro G (2007) Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 17(7):517–524. https://doi.org/10.1016/j.numecd.2006.04.002

Article  CAS  PubMed  Google Scholar 

Keane JT, Elangovan H, Stokes RA, Gunton JE (2018) Vitamin D and the liver-correlation or cause? Nutrients 10(4):496. https://doi.org/10.3390/nu10040496

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Xu MJ, Zhang W, Qian HM, Li WH, Cheng X, Bo X (2020) Active vitamin D supplementation alleviates initiation and progression of nonalcoholic fatty liver disease by repressing the p53 pathway. Life Sci 241:117086. https://doi.org/10.1016/j.lfs.2019.117086

Article  CAS  PubMed  Google Scholar 

Kitson MT, Pham A, Gordon A, Kemp W, Roberts SK (2016) High-dose vitamin D supplementation and liver histology in NASH. Gut 59:102570. https://doi.org/10.1136/gutjnl-2015-310417

Article  CAS  Google Scholar 

Liu P, Anandhan A, Chen J et al (2023) Decreased autophagosome biogenesis, reduced NRF2, and enhanced ferroptotic cell death are underlying molecular mechanisms of non-alcoholic fatty liver disease. Redox Biol 59:102570. https://doi.org/10.1016/j.redox.2022.102570

Article  CAS  PubMed  Google Scholar 

Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266–282. https://doi.org/10.1038/s41580-020-00324-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Li X, Ge C, Min J, Wang F (2022) The multifaceted role of ferroptosis in liver disease. Cell Death Differ 29(3):467–480. https://doi.org/10.1038/s41418-022-00941-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang JJ, Zhang GF, Zheng JY, Sun JH, Ding SB (2022) Targeting mitochondrial ROS-Mediated ferroptosis by Quercetin alleviates high-Fat Diet-Induced hepatic lipotoxicity. Front Pharmacol 13:876550. https://doi.org/10.3389/fphar.2022.876550

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Jin C, Shen M, Wang Z, Tan S, Chen A, Wang S, Shao J, Zhang F, Zhang Z, Zheng S (2020) Iron regulatory protein 2 is required for artemether -mediated anti-hepatic fibrosis through ferroptosis pathway. Free Radic Biol Med 160:845–859. https://doi.org/10.1016/j.freeradbiomed.2020.09.008

Article  CAS  PubMed  Google Scholar 

Cheng K, Huang Y, Wang C (2021) 1,25(OH)2D3 inhibited ferroptosis in zebrafish liver cells (ZFL) by regulating Keap1-Nrf2-GPx4 and NF-κB-hepcidin Axis. Int J Mol Sci 22(21):11334. https://

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vargas J, Roschzttardtz H (2023) Perls/DAB staining to Examine Iron distribution in Arabidopsis embryos. Methods Mol Biol 2665:173–176. https://doi.org/10.1007/978-1-0716-3183-6_13

Article  CAS  PubMed  Google Scholar 

Mertens J, De Block C, Spinhoven M, Driessen A, Francque SM, Kwanten WJ (2021) Hepatopathy Associated with type 1 diabetes: distinguishing non-alcoholic fatty liver Disease from Glycogenic Hepatopathy. Front Pharmacol 12:768576. https://doi.org/10.3389/fphar.2021.768576

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zakaria Z, Othman ZA, Suleiman JB, Che Jalil NA, Ghazali WSW, Nna VU, Mohamed M (2021) Hepatoprotective Effect of Bee Bread in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Rats: Impact on Oxidative Stress and Inflammation. Antioxidants (Basel) 10(12): 2031. https://doi.org/10.3390/antiox10122031

Surmacki JM, Quiros-Gonzalez I, Bohndiek SE (2022) Evaluation of Label-Free Confocal Raman Microspectroscopy for Monitoring oxidative stress in Vitro in Live Human Cancer cells. Antioxid (Basel) 11(3):573. https://doi.org/10.3390/antiox11030573

Article  CAS  Google Scholar 

Zhang L, Yu J, Ye M, Zhao H (2019) Upregulation of CKIP-1 inhibits high-glucose induced inflammation and oxidative stress in HRECs and attenuates diabetic retinopathy by modulating Nrf2/ARE signaling pathway: an in vitro study. Cell Biosci 9:67. https://doi.org/10.1186/s13578-019-0331-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng G, Byrne CD, Targher G, Wang F, Zheng MH (2022) Ferroptosis and metabolic dysfunction-associated fatty liver disease: is there a link? Liver Int 42(7):1496–1502. https://doi.org/10.1111/liv.15129.63

Article  PubMed  Google Scholar 

Kim GH, Jeong HJ, Lee YJ et al (2024) Vitamin D ameliorates age-induced nonalcoholic fatty liver disease by increasing the mitochondrial contact site and cristae organizing system (MICOS) 60 level. Exp Mol Med 56(1):142–155. https://doi.org/10.1038/s12276-023-01125-7